Drug Type Bispecific antibody |
Synonyms Targeting TSLP and IL-11 IgG1-type Bispecific Antibody(Shanghai Huaaotai Biopharmaceutical) |
Target |
Mechanism IL-11 modulators(interleukin 11 modulators), TSLP modulators(Thymic stromal lymphopoietin modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | IND Approval | NZ | 01 Nov 2024 |